Hepatic Disease Clinical Trial
Official title:
Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting
To establish the performance characteristics of the Samsung LABGEO PT10 by comparing the test results of the PT10 Hepatic assay with results obtained from an FDA-cleared chemistry analyzer.
To establish the correlation between measurand values as obtained from the Samsung LABGEO PT10 Hepatic Panel at the point of care, and the corresponding measurand values as obtained on a commercial clinical chemistry analyzer, with respect to prospectively collected human serum specimens. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05593211 -
Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures
|
N/A | |
Not yet recruiting |
NCT06153394 -
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
|
Phase 3 | |
Completed |
NCT03652636 -
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions
|
Phase 4 | |
Recruiting |
NCT03297073 -
Paracetamol Metabolism Research in Postoperative Hepatic Surgery
|
N/A | |
Recruiting |
NCT05822635 -
SpyGlass Surgical Study
|
||
Not yet recruiting |
NCT05616442 -
Ketotifen in Non-Alcoholic Fatty Liver Disease Patients
|
Phase 4 | |
Completed |
NCT03767517 -
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
|
N/A |